Rob Fowler

TL;DR: There are a growing number of evidence-based strategies for VAP prevention, which, if applied in practice, may reduce the incidence of this serious nosocomial infection.

TL;DR: The Adenoma Prevention With Celecoxib (APC) trial as discussed by the authors used 400 mg once daily to test the efficacy and safety of celecoxib against placebo in reducing colorectal adenoma recurrence after polypectomy.

TL;DR: Evidence-based recommendations for the diagnosis and treatment of Ventilator-associated pneumonia are presented and implementation of these recommendations into clinical practice may lessen the morbidity and mortality of patients who develop VAP.

TL;DR: One third of very elderly ICU patients died in hospital, many after a prolonged ICU stay while continuing to receive aggressive life-sustaining interventions, raising questions about the use of critical care at the end of life for the very elderly.